Eupraxia Pharmaceuticals Reports Positive Data From RESOLVE Trial

MT NewswiresSep 11 08:15 ET

Eupraxia's EP-104GI Shows Promise in EoE Trial

TipRanksSep 11 07:27 ET

Eupraxia Pharmaceuticals Brief: Announcing Data From RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

MT NewswiresSep 11 07:02 ET

Eupraxia Pharmaceuticals Announces Data From RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

PR NewswireSep 11 07:00 ET

Press Release: Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results

Dow JonesAug 7 17:00 ET

Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo

PR NewswireJul 8 07:00 ET